PRIMARY STUDY
Electroacupuncture Reduces Visceral Pain Via Cannabinoid CB2 Receptors in a Mouse Model of Inflammatory Bowel Disease
Key Findings: Data revealed that the use of electroacupuncture reduces visceral pain via CB2 in a Mouse Model of Inflammatory Bowel Disease. More specifically, a pair of stainless steel acupuncture needles were inserted into bilateral sides of Dachangshu (BL25) acupoint.
Type of Study: Animal Study
Study Result: Positive
Research Location(s): China, United States
Year of Pub: 2022
Cannabinoids Studied: Acupuncture (TCM)
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB2
Ligands Studied: Anti-inflammatory cytokines, Pro-inflammatory cytokines
Citation: Zhang H, et al. Electroacupuncture Reduces Visceral Pain Via Cannabinoid CB2 Receptors in a Mouse Model of Inflammatory Bowel Disease. Front Pharmacol. 2022; 13:861799. doi: 10.3389/fphar.2022.861799
Authors: Zhang H, He W, Hu XF, Li YZ, Liu YM, Ge WQ, Zhanmu OY, Chen C, Lan YY, Su YS, Jing XH, Zhu B, Pan HL, Yu LL, Li M
